Lloyds Enterprises Regulatory Approval

Other Announcement

Lloyds Enterprises Other Announcement

Lloyds Enterprises Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. This is a routine regulatory compliance disclosure.

Employee Stock Options

Lloyds Enterprises Employee Stock Options

Lloyds Enterprises granted 1,35,440 ESOPs under its 2025 plan at Rs. 2 per option. Options carry a one-year minimum vesting and three-year exercise window.

Price Movement Clarification

Lloyds Enterprises Price Movement Clarification

Lloyds Enterprises Limited clarified that the recent increase in share trading volume is purely market-driven. The company confirmed it has no undisclosed price-sensitive information at this time.

Debt & Borrowing

Lloyds Enterprises Debt & Borrowing: ₹40 Cr

Lloyds Enterprises Limited informed that Tata Capital Limited assigned a portion of its loan facility, amounting to ₹40 Crore, to Aditya Birla Capital Limited.

Value

₹40.00 Cr

Legal & Regulatory

Lloyds Enterprises Legal & Regulatory

Lloyds Enterprises settled SEBI enforcement proceedings related to a 2025 show-cause notice. The company paid a combined settlement amount of Rs. 4.16 Crore.

Value

₹4.16 Cr

Legal & Regulatory

Lloyds Enterprises Legal & Regulatory

Lloyds Enterprises Limited settled enforcement proceedings with SEBI regarding alleged violations of PFUTP and LODR regulations. The settlement order disposes of the show-cause notice without financial impact.

Regulatory ApprovalShalby Ltd SHALBYAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Shalby Regulatory Approval

Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.

Regulatory ApprovalElantas Beck India Ltd ELANTASAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Elantas Beck India Regulatory Approval

Elantas Beck India's GPCB permanently revoked the closure direction on its Ankleshwar plant. The facility can keep operating, subject to compliance conditions.

Regulatory ApprovalKalyani Cast-Tech Ltd 544023Alfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Kalyani Cast-Tech Regulatory Approval

Kalyani Cast-Tech received RDSO Stage-I concept design approval for its new container-carrying wagon under PWDA. Stage-II detailed design approval is still required, subject to dynamics simulation conditions.

Regulatory ApprovalMukka Proteins Ltd MUKKAAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Mukka Proteins Regulatory Approval

Mukka Proteins received a US FDA facility registration certificate, valid October 1, 2026 to December 31, 2027. The company says the registration supports its engagement with US customers and markets.

Execution

October 1, 2026 to December 31, 2027

Regulatory ApprovalCanara Bank CANBKAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Canara Bank Regulatory Approval

Canara Bank received RBI permission to exercise the call option on its Basel III AT1 bonds (ISIN INE476A08134) of Rs.1,500 Crore. The bank is now in process of exercising the call as per the issue terms.

Value

₹1,500 Cr

Regulatory ApprovalAlembic Pharmaceuticals Ltd APLLTDAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Alembic Pharmaceuticals Regulatory Approval

Alembic Pharmaceuticals received USFDA final approval for Valganciclovir for Oral Solution, 50 mg/mL. This adds to its cumulative 247 USFDA ANDA approvals.